Wu, Wenwen <br/><br/>
The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy.  [electronic resource] 

 -  Oncology reports   
 - 1027-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1021-335X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis<br/>Breast Neoplasms--drug therapy<br/>Carcinoma, Intraductal, Noninfiltrating--drug therapy<br/>Cell Division<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Immunohistochemistry<br/>In Situ Nick-End Labeling<br/>Ki-67 Antigen--biosynthesis<br/>Middle Aged<br/>Paclitaxel--administration & dosage<br/>Taxoids<br/>Treatment Outcome